On Invalid Date, Agenus (NASDAQ: AGEN) reported Q4 2023 earnings per share (EPS) of -$2.40, up 50% year over year. Total Agenus earnings for the quarter were -$46.34 million. In the same quarter last year, Agenus's earnings per share (EPS) was -$4.80.
As of Q2 2024, Agenus's earnings has grown year over year. Agenus's earnings in the past year totalled -$245.97 million.
What is AGEN's earnings date?
Agenus's earnings date is Invalid Date. Add AGEN to your watchlist to be reminded of AGEN's next earnings announcement.
What was AGEN's revenue last quarter?
On Invalid Date, Agenus (NASDAQ: AGEN) reported Q4 2023 revenue of $83.80 million up 195.22% year over year. In the same quarter last year, Agenus's revenue was $28.39 million.
What was AGEN's revenue growth in the past year?
As of Q2 2024, Agenus's revenue has grown 59.47% year over year. This is 91.99 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Agenus's revenue in the past year totalled $156.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.